Search results for: ai
Cryoablation and its Effects on Cancer Pain
An underappreciated use of cryoablation is increasing — pain management in cancer patients. A 2021 study released by the Radiological Society of North America (RSNA) confirms that cryoablation is a safe, effective treatment of pain caused by metastatic bone tumors. An article by J. David Prologo, an interventional radiologist at Emory Healthcare in Atlanta, published…
Read MoreOutside Threats to the Image-Guided Bone Pain Relief Market
Radiology dominates the rapidly increasing market for image-guided ablation for bone pain, most often caused by cancer that has metastasized to the bones. Upwards of 80% of metastatic breast, lung, and prostate cancers develop osseous metastases as the patient’s cancer spreads to the bones. Over three-quarters of these patients develop pain. Mona Ranade, MD, an…
Read MoreCMS Requires COVID-19 Vaccination by January 4th for Facilities that Accept Medicare and Medicaid
CMS announced an emergency order requiring every healthcare facility, who participates in Medicare and Medicaid programs to ensure that all eligible employees receive COVID-19 vaccination by January 4, 2022. The emergency order applies to approximately 76,000 facilities that employ more than 17 million healthcare workers. Applicable facilities include: Ambulatory Surgery Centers Clinics Community Mental Health…
Read MoreRadiology Board Claim They Are Unable To Reduce Exam Fees
The American Board of Radiology revealed recently that it has experienced “persistent barriers” in preventing them from reducing exam fees following its transition to a virtual test-taking model. The board is making the switch away from in-person certification in 2021 after radiologists demanded alternatives for their safety amid the COVID-19 pandemic. One of the “perceived…
Read MoreVaccine Shows Effective Against U.K. Variant Of Virus
Phase 2/3 trials show that the AstraZeneca/University of Oxford vaccine are effective against the new U.K. variant. In a pre-print, not yet reviewed by The Lancet, Andrew Pollard, PhD, University of Oxford, claims vaccine efficacy was 74.9% (95% CI 41.6-88.9) after two doses against symptomatic infection from the B.1.1.7 variant. CDC estimates it could be…
Read More